Iveta Zmetakova
Overview
Explore the profile of Iveta Zmetakova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
226
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kalinkova L, Kajo K, Karhanek M, Wachsmannova L, Suran P, Zmetakova I, et al.
Int J Mol Sci
. 2020 Aug;
21(17).
PMID: 32842533
The discrimination of different subtypes of endometrial carcinoma (EC) is frequently problematic when using the current histomorphological classification; therefore, new markers for this differentiation are needed. Here, we examined differences...
2.
Fridrichova I, Zmetakova I
Cells
. 2019 Nov;
8(11).
PMID: 31683635
Cancer statistics in 2018 highlight an 8.6 million incidence in female cancers, and 4.2 million cancer deaths globally. Moreover, breast cancer is the most frequent malignancy in females and twenty...
3.
Zmetakova I, Kalinkova L, Smolkova B, Kajabova V, Cierna Z, Danihel L, et al.
Cancer Sci
. 2019 Mar;
110(5):1695-1704.
PMID: 30815959
A Disintegrin And Metalloprotease 23 (ADAM23), a member of the ADAM family, is involved in neuronal differentiation and cancer. ADAM23 is considered a possible tumor suppressor gene and is frequently...
4.
Kalinkova L, Zmetakova I, Smolkova B, Minarik G, Sedlackova T, Kajabova V, et al.
BMC Cancer
. 2018 Sep;
18(1):875.
PMID: 30189837
Background: In breast cancer (BC), deregulation of DNA methylation leads to aberrant expressions and functions of key regulatory genes. In our study, we investigated the relationship between the methylation profiles...
5.
Jurkovicova D, Smolkova B, Magyerkova M, Sestakova Z, Kajabova V, Kulcsar L, et al.
Oncotarget
. 2017 Nov;
8(44):77369-77384.
PMID: 29100393
Deregulated expression of microRNAs has the oncogenic or tumor suppressor function in cancer. Since miRNAs in plasma are highly stable, their quantification could contribute to more precise cancer diagnosis, prognosis...
6.
Smolkova B, Mego M, Kajabova V, Cierna Z, Danihel L, Sedlackova T, et al.
Transl Oncol
. 2016 Jun;
9(3):184-90.
PMID: 27267835
Circulating tumor cells (CTCs) are independent prognostic factors in the primary and metastatic breast cancer patients and play crucial role in hematogenous tumor dissemination. The aim of this study was...
7.
Fridrichova I, Smolkova B, Kajabova V, Zmetakova I, Krivulcik T, Mego M, et al.
Transl Res
. 2015 Jan;
165(6):717-30.
PMID: 25620615
More than 25% of the patients with breast cancer (BC) develop metastatic disease. In the present study, we investigated the relationship between DNA methylation levels in genes regulating cell growth,...
8.
Kajabova V, Smolkova B, Zmetakova I, Sebova K, Krivulcik T, Bella V, et al.
Transl Oncol
. 2013 Jun;
6(3):297-304.
PMID: 23730409
The aim of this study was to investigate the relationship between the promoter methylation in five cancer-associated genes and clinicopathologic features for identification of molecular markers of tumor metastatic potential...
9.
Sebova K, Zmetakova I, Bella V, Kajo K, Stankovicova I, Kajabova V, et al.
Cancer Biomark
. 2012 Feb;
10(1):13-26.
PMID: 22297548
Breast cancer is the most common cancer in women worldwide, representing 28.2% of all female malignancies. In addition to genetic changes, epigenetic events, as aberrant DNA methylation and histone modification,...